Revvity Inc. $RVTY Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC cut its stake in Revvity Inc. (NYSE:RVTY) by 47.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,260 shares of the company’s stock after selling 4,782 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Revvity were worth $461,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Byrne Asset Management LLC lifted its stake in shares of Revvity by 0.9% in the 4th quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock valued at $1,078,000 after purchasing an additional 100 shares during the last quarter. New Mexico Educational Retirement Board lifted its position in Revvity by 1.9% in the fourth quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company’s stock valued at $524,000 after buying an additional 100 shares during the last quarter. Allworth Financial LP boosted its stake in Revvity by 8.9% during the fourth quarter. Allworth Financial LP now owns 1,275 shares of the company’s stock worth $123,000 after buying an additional 104 shares during the period. Trust Point Inc. increased its position in shares of Revvity by 3.8% during the fourth quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock valued at $311,000 after acquiring an additional 117 shares during the last quarter. Finally, HighTower Advisors LLC raised its stake in shares of Revvity by 2.6% in the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock valued at $497,000 after acquiring an additional 129 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Up 0.2%

Shares of NYSE RVTY opened at $111.43 on Thursday. The business has a 50-day moving average price of $103.12 and a 200 day moving average price of $98.97. The stock has a market cap of $12.43 billion, a PE ratio of 53.32, a price-to-earnings-growth ratio of 2.19 and a beta of 1.09. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $118.30.

Revvity (NYSE:RVTY) last announced its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The business had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. During the same quarter in the prior year, the firm earned $1.01 earnings per share. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities research analysts forecast that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is 13.40%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Sanford C. Bernstein started coverage on Revvity in a report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective on the stock. Robert W. Baird set a $117.00 price target on shares of Revvity in a research note on Wednesday, May 6th. Barclays raised their price objective on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. TD Cowen reiterated a “buy” rating on shares of Revvity in a report on Wednesday. Finally, Zacks Research cut shares of Revvity from a “hold” rating to a “strong sell” rating in a research report on Monday, July 6th. Four analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Revvity has a consensus rating of “Hold” and an average price target of $108.92.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.